v3.24.3
Unaudited Interim Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Operating activities    
Net loss from continuing operations $ (42,507) $ (40,472)
Adjustments to reconcile net loss to net cash provided by operating activities    
Non-cash adjustments of inventory   728
Accretion expense 9,162 7,497
Depreciation of property and equipment and amortization of intangible assets 15,029 15,179
Amortization of operating right-of-use assets 2,185 1,630
Share-based compensation 7,720 5,469
Deferred income tax (recovery) expense (986) 1,099
(Gain) loss on fair value of derivative liabilities and purchase option derivative assets (2,608) 2,564
Gain on disposal of fixed assets (9) (1,534)
Unrealized and realized loss on investments 213 2,365
Loss (gain) from revaluation of contingent consideration 3,547 (645)
Impairment of property and equipment and right of use assets 2,438  
Gain on lease termination and derecognition of finance lease (1,220)  
Bad debt recovery (1,136)  
Loss on extinguishment of debt 1,662  
Unrealized and realized foreign exchange loss (gain) 175 (175)
Changes in operating assets and liabilities    
Receivables 428 (5,224)
Inventory 1,559 (10,750)
Prepaid expense and other current assets (1,303) (808)
Deposits 53 411
Other assets 77 718
Accounts payable and accrued liabilities and other payables (7,812) 7,395
Operating lease liability (1,804) (1,566)
Other liability (473) 1,542
Uncertain tax position liabilities 36,698  
Corporate income tax payable 6,300 35,140
Deferred revenue 815 1,149
Net cash provided by operating activities- continuing operations 28,203 21,712
Net cash used in operating activities - discontinued operations   (3,660)
Net cash provided by operating activities 28,203 18,052
Investing activities    
Investment in property and equipment (4,623) (6,224)
Investment in note receivable, net of interest received (1,523)  
Investment in intangible assets (115) (262)
Insurance recovery for property and equipment 871  
Success fees related to Alternative Treatment Center license   (3,750)
Receipt of convertible debenture payment   738
Payment for land contracts (630) (1,047)
Cash portion of consideration paid in acquisitions, net of cash of acquired (250) (17,032)
Net cash used in investing activities - continuing operations (6,270) (27,577)
Net cash provided investing activities - discontinued operations   14,285
Net cash used in investing activities (6,270) (13,292)
Financing activities    
Transfer of Employee Retention Credit   12,677
Proceeds from loan payable, net of transaction costs 129,382 23,869
Proceeds from options and warrants exercised   81
Loan principal paid (144,771) (46,029)
Loan amendment fee paid and prepayment premium paid   (1,178)
Capital distributions paid to non-controlling interests (4,433) (6,966)
Proceeds from private placement, net of share issuance costs   21,260
Payments made for financing obligations and finance lease (356) (1,158)
Repurchases of common shares (138)  
Net cash (used in) provided by financing activities- continuing operations (20,316) 2,556
Net cash used in financing activities- discontinued operations   (5,539)
Net cash used in financing activities (20,316) (2,983)
Net increase in cash and cash equivalents and restricted cash during the period 1,617 1,777
Net effects of foreign exchange 278 (24)
Cash and cash equivalents and restricted cash, beginning of the period 25,347 26,763
Cash and cash equivalents and restricted cash, end of the period 27,242 28,516
Supplemental disclosure with respect to cash flows    
Cash received for income tax, net (8,449) (4,582)
Interest paid 17,931 16,683
Lease termination fee paid 271 217
Non-cash transactions    
Equity and warrant liability issued for acquisitions and non-controlling interest 4,674 8,600
Equity issued for price protection on contingent consideration 693  
Accrued capital purchases $ 526 936
Warrant issued as consideration for services   1,000
Promissory note issued as consideration for acquisitions   11,689
Shares issued for legal and liability settlement   $ 794

Source

10-Q PDF
XBRL